Live feed09:00:00·1633dPRReleasevia QuantisnowZealand Pharma Presents Financial Results for the First Nine Months of 2021; Provides Updates on Commercial Launch and Timing for Congenital Hyperinsulinism and Short Bowel Syndrome Phase Three Clinical StudiesByQuantisnow·Wall Street's wire, on your screen.ZEAL· Zealand Pharma A/SHealth Care
